Reported 28 days ago
Pfizer's CEO Albert Bourla shared insights on their impressive third quarter performance, highlighting strong revenue from both COVID and non-COVID sectors. While addressing concerns about the sustainability of the COVID business, he noted its stabilization. Engaging in a proxy battle with activist investor Starboard Value, Bourla acknowledged some criticisms regarding shareholder returns but maintained confidence in his strategy and recent changes at Pfizer aimed at enhancing shareholder value.
Source: YAHOO